Short-term glucose variability in healthy volunteers is not associated with raised oxidative stress markers

被引:9
作者
Wakil, A. [1 ]
Smith, A. [2 ]
Atkin, S. L. [3 ]
Kilpatrick, E. S. [2 ]
机构
[1] Hull Royal Infirm, Michael White Diabet Ctr, Kingston Upon Hull HU3 2JZ, N Humberside, England
[2] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England
[3] Hull York Med Sch, Dept Diabet Endocrinol & Metab, Kingston Upon Hull, N Humberside, England
关键词
diabetes complications; microvascular; somatostatin; FLUCTUATIONS; RESISTANCE; ACTIVATION; RISK;
D O I
10.1111/j.1463-1326.2012.01625.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is unknown whether glycaemic variability adds to the risk of microvascular complications of diabetes over and above the mean glucose value for a patient. We examined the effect of purposefully induced short-term glycaemic variability on oxidative stress markers. Eleven healthy subjects underwent three sequential glycaemic states; sustained hyperglycaemia, sustained euglycaemia and variable glycaemia, using glycaemic clamps for 3?h. Twenty-four hours urinary 8-isoprostane-PGF2a was measured before and after each glycaemic state to assess oxidative stress. The median and interquartile range of the urinary 8-iso-PGF2a in ng/24?h were (1373, 513), (996, 298) and (1227, 472) for the euglycaemic, hyperglycaemic and variable states, respectively. There was no significant difference in urinary isoprostanes between the three different states; mean ranks 20.9, 11.9 and 18.2 for the euglycaemic state, hyperglycaemic state and glycaemic variability state, respectively, p = 0.083. In conclusion, we did not see a significant increase in the urinary isoprostanes when glycaemic variability was induced under controlled conditions in healthy individuals.
引用
收藏
页码:1047 / 1049
页数:3
相关论文
共 12 条
[1]   'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting [J].
Ceriello, A. ;
Ihnat, M. A. .
DIABETIC MEDICINE, 2010, 27 (08) :862-867
[2]   Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients [J].
Ceriello, Antonio ;
Esposito, Katherine ;
Piconi, Ludovica ;
Ihnat, Michael A. ;
Thorpe, Jessica E. ;
Testa, Roberto ;
Boemi, Massimo ;
Giugliano, Dario .
DIABETES, 2008, 57 (05) :1349-1354
[3]  
DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
[4]   Biomarkers of oxidative stress study II.: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? [J].
Kadiiska, MB ;
Gladen, BC ;
Baird, DD ;
Germolec, D ;
Graham, LB ;
Parker, CE ;
Nyska, A ;
Wachsman, JT ;
Ames, BN ;
Basu, S ;
Brot, N ;
FitzGerald, GA ;
Floyd, RA ;
George, M ;
Heinecke, JW ;
Hatch, GE ;
Hensley, K ;
Lawson, JA ;
Marnett, LJ ;
Morrow, JD ;
Murray, DM ;
Plastaras, J ;
Roberts, LJ ;
Rokach, J ;
Shigenaga, MK ;
Sohal, RS ;
Sun, J ;
Tice, RR ;
Van Thiel, DH ;
Wellner, D ;
Walter, PB ;
Tomer, KB ;
Mason, RP ;
Barrett, JC .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (06) :698-710
[5]   For debate.Glucose variability and diabetes complication risk: we need to know the answer [J].
Kilpatrick, E. S. ;
Rigby, A. S. ;
Atkin, S. L. .
DIABETIC MEDICINE, 2010, 27 (08) :868-871
[6]   The effect of glucose variability on the risk of microvascular complications in type 1 diabetes [J].
Kilpatrick, Eric S. ;
Rigby, Alan S. ;
Atkin, Stephen L. .
DIABETES CARE, 2006, 29 (07) :1486-1490
[7]   Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes [J].
Monnier, L ;
Mas, E ;
Ginet, C ;
Michel, F ;
Villon, L ;
Cristol, JP ;
Colette, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1681-1687
[8]   Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy [J].
Monnier, L. ;
Colette, C. ;
Mas, E. ;
Michel, F. ;
Cristol, J. P. ;
Boegner, C. ;
Owens, D. R. .
DIABETOLOGIA, 2010, 53 (03) :562-571
[9]   Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM [J].
Santini, SA ;
Marra, G ;
Giardina, B ;
Cotroneo, P ;
Mordente, A ;
Martorana, GE ;
Manto, A ;
Ghirlanda, G .
DIABETES, 1997, 46 (11) :1853-1858
[10]  
Siegelaar Sarah E, 2011, J Diabetes Sci Technol, V5, P86